I only notified for biologic product deviations. You also have to notify in case of a transfusion associated fatality. You should already have those policies written. No need to have a separate one that includes both as long as they are already there. That standard doesn't need to be achieved with a single policy. As long as you meet it.
We have placed cookies on your device to help make this website better. You can adjust your cookie settings, otherwise we'll assume you're okay to continue.